News | February 09, 2010

Molecular Imaging Role Critical in Patients with Cognitive Disorders

February 9, 2010 - Nuclear medicine and molecular imaging professionals discussed the critical role of molecular imaging in the diagnostic approach to patients with cognitive disorders, as well as other clinical topics during SNM's 2010 Conjoint Mid-Winter Meetings.

Four meetings were held in succession, including the 2010 Annual Meeting and Educational Symposium of the American College of Nuclear Medicine (ACNM) and SNM's Mid-Winter Educational Symposium, Nanomedicine and Molecular Imaging Summit and Clinical Trials Network Community Workshop.

The ACNM Annual Meeting and Educational Symposium took place first and featured lectures about the use of PET/CT in the brain and neck, genitourinary system, head and neck cancer and thyroid cancer. This was the first gathering of the organization since it officially merged in September with the American College of Nuclear Physicians.

SNM's Mid-Winter Educational Symposium began at the conclusion of ACNM's meeting, keeping attendees busy with a robust schedule of in-depth educational sessions and exhibits. The symposium included numerous educational sessions designed in collaboration with SNM's councils, centers of excellence, Technologist Section (SNMTS) and Clinical Trials Network.

"Integrated Imaging for Clinical Diagnosis and Treatment of Heart Failure in 2010" updated cardiologists, nuclear medicine physicians and scientists about current understanding and recent developments in the multimodality imaging assessment of heart failure. Back by popular demand, the two-day CT case review session challenged and instructed physicians with 100 cases and 16 hours of continuing education credits.

In the session, "The Sharp Edges of Nuclear Medicine: See What's New," technologists were introduced to the newest techniques in fusion imaging, with a focus on patients with epilepsy. In addition, technologists attended a new session, cosponsored by SNMTS and the American Society of Radiologic Technologists, titled "Nuclear Medicine Unfolded: What You Need to Know." The session focused on legislative and regulatory issues that nuclear medicine technologists face, including USP , the recently reintroduced CARE bill and the Medicare Improvement Providers and Patients Act of 2008 (MIPPA).

"We think this year's educational symposium provided attendees with the most comprehensive information in nuclear medicine and molecular imaging," said Peter Herscovitch, M.D., chair of SNM's Scientific Program Committee. "We were pleased to offer yet another excellent opportunity for leaders in the field to come together in one place to share their ideas."

The Nanomedicine and Molecular Imaging Summit followed on the heels of the symposium, Jan. 31–Feb. 1. This SNM summit, which featured sessions led by more than 20 experts from a variety of fields, took an exciting look at what the future holds for nanomedicine, as well as molecular imaging's role in its development and application.

The SNM Clinical Trials Network Community Workshop capped off the mid-winter meeting on Feb.1­–2, giving participants important information about molecular imaging in clinical trials. Topics discussed included clinical research imaging technologist certification curriculum, multisite imaging challenges for investigational therapeutics clinical trials and site qualification via the SNM Clinical Trials Network phantom program.

For more information: www.snm.org

Related Content

PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone of its imaging...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Netherlands Cancer Institute Exploring Molecular Imaging Technology for Prostate Cancer Surgery
News | Molecular Imaging | October 26, 2017
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
Overlay Init